Publication:
Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells

Simple item page
dc.contributor.affiliation"IMDEA Nanoscience, Madrid, Spain"," Fundación de Investigación HM Hospitales, Madrid, Spain"," Istitute of Applied Molecular Medicine, Faculty of Medicine, San Pablo CEU University, Madrid, Spain"," Molecular Pathology Laboratory, Institute of Biochemistry and Microbiology, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile"," Instituto de Salud Carlos III, Madrid, Spain"," Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland"," Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, United States"," Madrid, Spain"," Atrys Health, Barcelona, Spain"," Brain Tumor Laboratory, Madrid, Spain"," Instituto de Investigaciones Biosanitarias, Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain"," Fundación de Investigación HM Hospitales, Institute of Applied Molecular Medicine, Faculty of Medicine, San Pablo CEU University, Madrid, Spain"en
dc.contributor.affiliation000000041762408X
dc.contributor.authorRackov G.
dc.contributor.authorIegiani G.
dc.contributor.authorUribe D.
dc.contributor.authorQuezada C.
dc.contributor.authorBelda-Iniesta C.
dc.contributor.authorEscobedo-Lucea C.
dc.contributor.authorSilva A.
dc.contributor.authorPuig P.
dc.contributor.authorGonzález-Rumayor V.
dc.contributor.authorAyuso-Sacido Á.
dc.date.accessioned2020-12-04T11:41:08Z
dc.date.available2020-12-04T11:41:08Z
dc.date.issued2020
dc.format.mimetypeapplication/pdfen
dc.identifier.doi10.3389/fonc.2020.01665en
dc.identifier.urihttp://hdl.handle.net/20.500.12614/761
dc.issue.number1665en
dc.journal.titleFrontiers in Oncologyen
dc.language.isoenen
dc.relation.projectIDinfo:eu:eu-repo/grantAgreement/////CHARACTERIZATION OF NOVEL MONOCLONAL ANTIBODIES ABLE TO IDENTIFY NEUROGENIC NICHES AND ARREST NEUROSPHERE PROLIFERATION AND DIFFERENTIATION/en
dc.relation.projectIDTEMPWe thank Rafael Samaniego from the Confocal Microscopy Unit (Instituto de Investigación Sanitaria Gregorio Marañon, Madrid, Spain) and Josefa Carrión-Navarro for technical help. This work was funded by the Spanish Ministry of Economy, Industry and Competitivity (RTC-2015-3846-1) grant to ÁA-S and VG-R, “Fondo de Investigaciones Sanitarias” (FIS) (PI17-01489), and the Miguel Servet program (CP11/00147 and CPII16/00056) from the Instituto de Salud Carlos III to ÁA-S. GR holds postdoctoral Juan de la Cierva Fellowship. GI was funded by Erasmus program. DU holds Doctorado Nacional CONICYT fellowship. CQ was funded by FONDECYT (N° 1160777). None of the funding institutions had the role in the design of the study and collection, analysis and interpretation of the data, and writing of the manuscript.
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsopen accessen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titlePotential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cellsen
dc.typeresearch articleen
dc.type.hasVersionVoRen
dc.volume.number10en
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Potential Therapeutic Effects of the.pdf
Size:
3.71 MB
Format:
Adobe Portable Document Format
Download

Collections

Publications